ad6

In line with our vision to be significant global player by 2010 A.D., Cadila Pharmaceuticals is fast emerging as a true Indian multinational.
As part of our strategy, we have wholly owned subsidiaries, joint ventures, strategic alliances, contract manufacturing, own marketing offices in 4 countries and have significant presence in over 46 countries across the globe. Our business revolves around the exports of formulations, bulk actives, hospital disposables, veterinary formulations and pharmaceutical machinery manufacturing.
Besides a significant presence in the Americas, CIS Countries, Africa, Central and South-East Asia, Oceanic Countries, Japan, Middle East and Europe, the company has offices in USA, Japan, Kenya, Nigeria, Russia, Kazakhstan and Ukraine. The International SBU plans to expand operations to more than 100 countries by 2010.
The focus is on building brands in the following therapeutic segments